Preemptive Conversion to mTOR Inhibition to Prevent Primary Cytomegalovirus Infection in Kidney Transplantation with High-Risk Serostatus
Preemptive conversion from mycophenolate to mTOR-I may be helpful to prevent or attenuate primary infection in CMV high-risk kidney transplant recipients. Differences were not statistically significant. A larger study, ideally a prospective randomized trial, is needed to validate these findings.
Authors
- Michael Sean Wiesener (ORCID: https://orcid.org/0000-0003-4992-3132)
- Katharina Heller (ORCID: https://orcid.org/0000-0002-9722-1242)
- Thomas Dienemann (ORCID: https://orcid.org/0000-0001-8846-3445)
- Hendrik Apel
- Anne Dieterle
- Mario Schiffer (ORCID: https://orcid.org/0000-0002-8414-1470)
- Jan Paulwitz
- Laura Vonbrunn
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Regensburg (DE)
- Universitätsklinikum Erlangen (DE)
- Comprehensive Cancer Center Erlangen (DE)
Publication Details
- Journal
- Transplantation Proceedings
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.transproceed.2025.03.029
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00